Pharma tariff relief likely short-lived with sector-specific duties on the horizon / Cheaper Wegovy, 23andMe shutters, and RFK Jr. cuts FDA jobs: Pharma news roundup / GLP-1s are driving returns on R&D investments for Big Pharma, report says / Telangana's aerospace & defence sector flexes muscle, flies past pharma in merchandise exports for April-Dec 2024 / Gilead's new HIV med, a bird flu shot for chickens, and Hims does blood tests: Pharma news roundup / Zepbound sales double, tariffs could hit Ozempic, and Pfizer on RFK Jr.: Pharma news roundup / Pharma is hopeful about Trump's second term -- here's what to expect for drugmakers / Pharma, med-tech seek sops to boost research / Trump's Ozempic tariffs, Zepbound on Medicare, and rising drug prices: Pharma news roundup / New drugs mean higher prices -- and a big year for Big Pharma

MS PHARMA

4 hours ago

Bookmark

Share

MS PHARMA is a company. It is part of the Health Care sector, specifically in the Pharmaceuticals industry.

Key facts

employees: 2,208 people
revenues: 253.8M $
sector: Health Care
industry: Pharmaceuticals
ESG score: 24.65 / 100

See more facts

LinkedIn: 70K followers

Extract data

Download datasets about MS PHARMA:

Stocks from MS PHARMA:

MS PHARMA is one of the companies in Pharmaceuticals, companies in Health Care and 3,550,070 companies in our database.

Talking Points

Loading ...
Improve our communities' quality of life by increasing the access to high quality and affordable products. | MS Pharma is a multinational pharmaceutical company specializing in the development, production, and distribution of generic and specialty medicines. With the introduction of a new senior leadership team lead by CEO Kalle Känd, a Corporate ...

Related

Connected or similar to MS PHARMA: .

This dashboard is based on data from: YAHOO-FIN, YFINANCE, Twitter.

This content is available under the CC BY 4.0 license.